chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shortness of breath; This is a spontaneous report from a contactable health care professional (patient). A 64-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 07Mar2021 at 15:00 (lot number was not reported) as dose number unknown, single for COVID-19 immunization.  The patient's medical history was not reported. The patient did not have COVID prior to vaccination. The patient did not receive other vaccines in four weeks. The patient received other unspecified medications in two weeks. The patient has not been tested for COVID post vaccination. The patient previously received Benadryl and experienced allergies. The patient reported that since she had the shot, she has been having shortness of breath that started on 10Mar2021. The patient did not receive treatment for the event. The outcome of the event was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Dizzinez, sensation of hot, nausea, blurry vision, pallor, suething. Low blood pressure measured after sympoms started to improve: 105/50, heart rate: 60. I drunk 600 ml of water and eat salt food. Recovered by 4:15 PM.
Information has been received from a Nurse Practitioner (N.P) concerning a 3 or 4 patients who on an unspecified date were vaccinated with a dose of VARIVAX (Merck).  It was reported that the patients complained about redness around the injection site.  It was reported that this was something that had not happened in the past.  Follow up information has been received from the nurse practitioner concerning a 9 year old male student with seasonal allergies who on 03-AUG-2009, at 2:15 P.M., was vaccinated subcutaneously with the second dose of VARIVAX (Merck) (lot # 664712/0799Y) into the left arm.  There was no illness at time of vaccination.  On 04-SEP-2009, at 4:55 P.M., the patient developed injection site red, hot and swollen.  No medical attention was sought.  On an unspecified date, the patient recovered.  This is one of several reports received from the same source.  Additional information is not expected.
NUMBNESS ON BOTTOM LIP, STARTED 45 MINS AFTER VACCINE. IT LASTED ABOUT 2 HRS.
Approximately 24 hours following the injection she experienced tingling in her bilateral fingers that progressed past her PIP joints she also developed the same type of tingling in her bilateral toes. There was no muscle weakness or loss of fine motor control.
She got her period two weeks early; This is spontaneous report from a contactable Nurse. This Nurse reported similar events for 3 patients. This is the first of 3 reports, reporting for one of the colleagues. A 41-year-old female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EK5730, exp: 31Mar2021, via an unspecified route of administration on 31Dec2020 at single dose for COVID-19 immunization. She was ANA and double strand is positive for autoimmune but it is watch and see thing. Patient's other medical history and concomitant medications were not reported.  Patient is not pregnant at the time of reporting. Reporter was wondering if other people were also reporting if they got their periods early. She got her period two weeks early (on 02Jan2021) and mentioned she also has two colleagues who had that as well on an unspecified date. The outcome of the event was reported as not recovered.  Information on the lot/batch number has been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021004161 same reporter/drug/AE, different patient;US-PFIZER INC-2021004222 same reporter/drug/AE, different patient
Patient reports high blood pressure daily since receiving vaccine for the past 2 weeks. No other changes to medications/diet/conditions.
This spontaneous report as received from a physician via an unspecified reporter, refers to a patient unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 07-MAR-2016, the patient was vaccinated with VAQTA "10Pk 25U/0.5 ml SD LLok w Cap Ped", lot # L030442 with expiration date 19-DEC-2016, which was stored at 1.11 Celsius Degrees for 216 hours. The type of excursion was refrigerator and the vaccine status was reported as "in excursion". There were no concomitant medications and adverse effects reported. No product quality complain was involved. This is one of several cases from the same reporter. Additional information has been requested.
Grandmother reported onset of high pitched cry which was different than any other cry she had heard from child, unsure of duration, approximately most of the evening. This occurred in the afternoon post vax on 1/11/00. Child was evaluated at the ER.
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant therapies were not reported. On 07-DEC-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 10 PK-0.5 ml SD-PFS LLokwTip, lot # L002310, expiration date 08-JUL-2016 (route and anatomical location of administration were unspecified) which was improperly stored in refrigerator to a temperature excursion of 1.1 Celsius degrees for 208 hours with lowest temperatures recorded of 34 Fahrenheit degrees. No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
SARS-CoV-2 test positive; SARS-CoV-2 test positive; I developed blood clots that were found in June after flying in a plane.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non healthcare professional). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Apr2021 14:30 (Batch/Lot number: unknown) at the age of 33 years as DOSE 2, SINGLE and administered in arm left, administration date 25Mar2021 14:20 (Batch/Lot number: unknown) as DOSE 1, SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 26Oct2021, outcome "unknown" and all described as "SARS-CoV-2 test positive"; THROMBOSIS (medically significant) with onset 21Jun2021 12:30, outcome "not recovered", described as "I developed blood clots that were found in June after flying in a plane.". The event "i developed blood clots that were found in june after flying in a plane." was evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (26Oct2021) positive, notes: Nasal Swab. Therapeutic measure Blood thinner medication was taken as a result of thrombosis.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
headache; tired; general feeling unwell; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient received bnt162b2 (BNT162B2), on 15Apr2021 as dose 1, single (Lot number: EW0164) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history included: "She also had covid before any of the Pfizer shots", start date: 06Jan2021 (unspecified if ongoing), notes: before any of the Pfizer shots; "Osteoporosis" (ongoing); "Breathing issue" (unspecified if ongoing), notes: 4 days in hospital breathing issue on oxygen supply for 3month; "Thyroid" (ongoing); "high cholesterol" (ongoing); "Stomach ache" (ongoing), notes: Protect stomachache from prednisone. Concomitant medication(s) included: ALENDRONATE SODIUM taken for osteoporosis (ongoing); PREDNISONE taken for polymyalgia rheumatica (ongoing); LEVOTHYROXINE taken for thyroid disorder (ongoing); PRAVASTATIN taken for blood cholesterol increased (ongoing); OMEPRAZOLE taken for abdominal pain upper (ongoing). The following information was reported: HEADACHE (non-serious), outcome "unknown"; FATIGUE (non-serious), outcome "unknown", described as "tired"; MALAISE (non-serious), outcome "unknown", described as "general feeling unwell".
I exp low grade fever,fatigue, body ache and chills lasing 4-5 days. The highest my fever got was 102.
Patient arrived at our vaccine event.  Filled out the Moderna Screening form and answered NO to having received a covid-19 vaccine previously.  Staff did a 2 person verification on her screening and felt it was safe to proceed and she met all of the guidelines.   Once the patient left the facility and when we were placing the vaccine into our state Alert system is when it was made clear she had already received a Pfizer vaccine on 5/24/21.  She was within the except able window to receive her 2nd dose but she got it with another vaccine.
Around 10 pm on 3/7/22 ,my son began having severe headache and sweats.  He slept on and off - having to relieve himself multiple time that night .  Around 3 am 3/8/22, he became light headed in the bathroom and fell.  He tried to get up a few minutes later (not sure if he hit his head but was very light headed) and fell again.  I found him on the floor and got him up only to have him fall again - hitting his side.  We got him in a chair because he was very weak.  He then proceeded to start shaking and his eyes rolled back and to me it looked like he was having a seizure.  I held his head because it was drooping and tried to have him focus on me since his eyes were rolling around.  After a few minutes, he was better.  My husband was calling 911 when I was dealing with him.  The EMTs came 12 minutes later (were in bathroom with him for at least 12 minutes) and checked his vitals.  They were fine, his pulse was a little high but everything else - oxygen, breathing and blood pressure were all good.  They checked his head and side but he only had bruising on his side and no lumps on his head.  They thought with him sweating thru his clothes, fever that is was due to J&J Vaccine and that he was dehydrated.  They didn't think he needed xrays and taking him to the doctor for followup would be fine.  So 3/8/22 - I took him to the doctor and they said he was fine but they took bloodwork to be sure it wasn't anything else.  Currently, we don't have those results back.  As I'm filling this out at 7 pm, he is fine having drank gatorade and apple juice today.  He still feels tired and a little off.
Blood sugar uncontrolled; Sore arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE ABNORMAL (Blood sugar uncontrolled), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE ABNORMAL (Blood sugar uncontrolled), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue). At the time of the report, BLOOD GLUCOSE ABNORMAL (Blood sugar uncontrolled) had resolved and PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment medication was not provided by the reporter.
Vaccine administered to left arm (sq) at 10:10am. At 10:22am a rash appeared across face. Dr. examined patient 10:23 1.5 ml of ZYRTEC was given. Patient monitored for 20 mins. Rash disappeared. Patient was stable with no wheezing nor discharge.
Pt fever prior to shots 100.7 rectal, 102.7 rectal on 10-17-18 after shots. 94.8 rectal on 2 thermometers and feels cool to touch. Pt responds normally and alert. This also happened after 4 mos shots on 8-22-18.
Significant pain in left deltoid after administered- later right deltoid, neck & shoulder pain 4 hours later dizziness & nausea.
Feeling very unwell; Nauseous; Diarrhea; Bad stomach pains; My arms hurt around my peck muscles; Experiencing acid reflux; Lightheadedness; GI symptoms; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 34-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EM9810), via an unspecified route of administration, administered in Arm Left on 14Feb2021 14:00 (at the age of 34-years-old) as dose 1, single for COVID-19 immunisation. Medical history included psoriatic arthropathy from an unknown date and unknown if ongoing , covid-19 from Nov2020 to an unknown date. Concomitant medications included amoxicillin (AMOXICILLIN) taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19. In pharmacy or drug store patient received vaccine facility. Since the vaccine on day 3, On 15Feb2021 13:00 I have been extremely nauseous, diarrhea, bad stomach pains. I did call my doctor but she said there was not anything to do. I wanted to know if what I am experiencing was normal because it does not seem to be getting any better. I am still feeling nauseous and have diarrhea. Also, my arms hurt around my peck muscles. I am not sure if I should get the second dose. Caller had Covid back in Nov of 2020 and reported feeling very unwell on unknown date. She received her first Covid vaccination on 14Feb2021. The day after receiving the vaccination she reported experiencing acid reflux and lightheadedness which are still continuing. She was due for the second vaccination soon and wanted to know if she should get it. She was seen by her physician yesterday for ongoing GI symptoms and physician recommended treatment for acid reflux. No treatment was received for the events. Patient visited Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 03Feb2021. The outcome of the event malaise was reported as unknown and while for other events was not recovered.  No follow-up attempts are possible. No further information is expected.
A  rash that was approximately two inches by three inches appeared at the injection site nine days after the vaccination.
"super sore arm."; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingles vaccine (received the previous shingles vaccine prior to the 1st dose of the Shingrix).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix about 2 years ago and not having any side effects from it except sore arm. The reporter consented to follow up. Not all information was available and was unable to provide the lot number, expiration for the vaccine.  The patient did give permission to follow up with their HCP and was unable to provide HCP's email and fax. For tolerances of 2nd dose, refer case US2021048462, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021048462:same patient, same reporter.
This spontaneous report has been received from a registered nurse, concerning a 64 year old (also reported as almost 65 year old) female patient. The patient's concurrent condition included multiple myeloma and allergy to statins, seafood and PERCOCET. Medical history or concomitant medications were not provided. On approximately 16-OCT-2017 (reported as about 1 week ago), the patient was vaccinated with PNEUMOVAX 23 (dose, frequency, lot number and expiration date were not provided) for prophylaxis. Approximately in October 2017, the reporter stated that patient experienced swollen and painful at the injection site, but not was red. The patient was treated with TYLENOL. The outcome of injection swollen and painful at the injection site was reported as not recovered. The causal relationship between swollen and painful at the injection site and the therapy with PNEUMOVAX 23 was not assessed.
Missed second dose ( Beyond Day 42); Broke out in hives; Blood Pressure very high after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Broke out in hives), HYPERTENSION (Blood Pressure very high after the first dose) and PRODUCT DOSE OMISSION ISSUE (Missed second dose ( Beyond Day 42)) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 82028) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Dec-2020, the patient experienced URTICARIA (Broke out in hives) and HYPERTENSION (Blood Pressure very high after the first dose). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose ( Beyond Day 42)). On 29-Dec-2020, URTICARIA (Broke out in hives) and HYPERTENSION (Blood Pressure very high after the first dose) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second dose ( Beyond Day 42)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication provided. No concomitant medication provided. Patient was referred to contact Health Care Provider whether to restart the vaccination series or continue with the second dose.
Patient states that after receiving the 1st dose of Shingrix 05/04/2021, started experiencing symptoms 05/05/2021 of injection site bruising and swelling. Primary communications recommendation treated with Dexamethasone. 10/19/2020 1st case of confirmed Shingles, 11/18/2020 2nd case of confirmed Shingles, 02/23/2021 3rd case of confirmed Shingles, and 06/2021 4th case of confirmed Shingles. 11/28/2021 treated for assumed case of Shingles due to previous history.
Patient started to smell chemical with in his nose internally when he breathes; This spontaneous case was reported by a consumer and describes the occurrence of PAROSMIA (Patient started to smell chemical with in his nose internally when he breathes) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A.) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PAROSMIA (Patient started to smell chemical with in his nose internally when he breathes). At the time of the report, PAROSMIA (Patient started to smell chemical with in his nose internally when he breathes) had not resolved.            No concomitant medications are included. No treatment details are provided. Action taken with mRNA-1273 in response to the event was not applicable.
Initial misuse report received from a healthcare professional on 14 February 2013. A part of dose was lost during vaccination due to leaking. No information was provided regarding the patient. No adverse event was reported. List of documents held by sender: none.
fever; was tired for a couple of days; heartbeat was unbelievably fast; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heartbeat was unbelievably fast), PYREXIA (fever) and FATIGUE (was tired for a couple of days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PALPITATIONS (heartbeat was unbelievably fast). On an unknown date, the patient experienced PYREXIA (fever) and FATIGUE (was tired for a couple of days). The patient was treated with PARACETAMOL (TYLENOL) on 16-Apr-2021 at a dose of 1 dosage form. At the time of the report, PALPITATIONS (heartbeat was unbelievably fast), PYREXIA (fever) and FATIGUE (was tired for a couple of days) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
DIZZY/LIGHT HEADED; STRANGE FEELING; OUT OF SORTS/DID NOT FEEL CONNECTED TO THE OUTSIDE WORLD; INCREASED PAIN; EXTREME HEADACHE; NAUSEOUS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included rheumatoid arthritis, fibromyalgia, superventricular tachycardia, low thyroid, and autoimmune disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 15-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 15-MAY-2021, the subject experienced dizzy/light headed. On 15-MAY-2021, the subject experienced nauseous. On 15-MAY-2021, the subject experienced out of sorts/did not feel connected to the outside world. On 15-MAY-2021, the subject experienced increased pain. On 15-MAY-2021, the subject experienced extreme headache. On 15-MAY-2021, the subject experienced strange feeling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dizzy/light headed, nauseous, out of sorts/did not feel connected to the outside world, increased pain, extreme headache and strange feeling was not reported. This report was non-serious.
Sciatic nerve pain in lower left leg. Causing numbness and sharp pain in the area as well. Numbness through the leg and into the toes.
WITHIN 5 TO 10 MINUTES OF RECEIVING THE VACCINE THE PATIENT SAID SHE FELT FUNNY AND HER FACE STARTED TINGLING. 25MG OF BENADRYL WAS GIVEN AT THAT TIME. WITHIN A FEW SECONDS OF THAT HER NOSE STARTED TINGLING AND SWELLING SHUT PER PATIENT JUST AS IT DID WITH HER PENICILLIN ALLERGY. THAT MOVED TO HER THROAT FEELING LIKE IT WAS SWELLING AND A DOSE OF EPINEPHRINE WAS GIVEN AND 911 WAS CALLED. EPI HELPED WITHIN A FEW SECONDS AND PATIENT LEFT THE BUILDING WITH THE EMTS TALKING AND BREATHING MUCH BETTER. SHE WAS DISCARGED AND IS NOW AT HOME.